Janux Shares Double After Positive Data From Ongoing Trials

By Stephen Nakrosis Shares of Janux Therapeutics doubled after hours Monday, following the release of data from ongoing dose escalation trials for...

Related Keywords

Stephen Nakrosis , ,Janux Therapeutics ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Biological Therapy ,Healthcare Provision ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Cancer ,Political General News ,Health ,Medical Conditions ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Janx ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Healthcare ,Life Sciences ,